Azimova M.R., Zhernakova Yu.V., Saidova M.A., Chazova I.E. Comparative evaluation new glucagon-like peptide 1 receptor agonist semaglutide and sodium-glucose cotransporter-2 inhibitors empagliflozin on left ventricular diastolic function in patients with arterial hypertension, obesity and type 2 diabetes mellitus. Systemic Hypertension. 2022;19(1):39-48. (In Russ.) https://doi.org/10.38109/2075-082X-2022-1-39-48
Email this article (Login required)
Email the author (Login required) OOO InterMedservice
Address: 121069, Russia, Moscow, Stolovy Lane, 6
Tel.: +7 (985) 763-98-00
e-mail: og@intermed.services
The media outlet is registered with the Federal Service for Supervision of Communications, Information Technology, and Mass Media (Roskomnadzor). Registration number and date of the decision on media registration: series EL No. FS 77 - 83918 dated 12.09.2022.
16+
Processing of personal data
